ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES

被引：0
作者：
Brunetti, C. [1 ]
Minervini, C. F. [1 ]
Orsini, P. [1 ]
Anelli, L. [1 ]
Zagaria, A. [1 ]
Coccaro, N. [1 ]
Tota, G. [1 ]
Minervini, A. [1 ]
Casieri, P. [1 ]
Cellamare, A. [1 ]
Cumbo, C. [1 ]
Impera, L. [1 ]
Ricco, A. [1 ]
Specchia, G. [1 ]
Albano, F. [1 ]
机构：
[1] Univ Bari, Hematol Sect, DETO, Bari, Italy
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30137-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
136
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [31] The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes
    Li, Xiang
    Marcondes, A. Mario
    Gooley, Theodore A.
    Deeg, H. Joachim
    BLOOD, 2010, 116 (13) : 2304 - 2314
  • [32] The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
    Nerea Berastegui
    Marina Ainciburu
    Juan P. Romero
    Paula Garcia-Olloqui
    Ana Alfonso-Pierola
    Céline Philippe
    Amaia Vilas-Zornoza
    Patxi San Martin-Uriz
    Raquel Ruiz-Hernández
    Ander Abarrategi
    Raquel Ordoñez
    Diego Alignani
    Sarai Sarvide
    Laura Castro-Labrador
    José M. Lamo-Espinosa
    Mikel San-Julian
    Tamara Jimenez
    Félix López-Cadenas
    Sandra Muntion
    Fermin Sanchez-Guijo
    Antonieta Molero
    Maria Julia Montoro
    Bárbara Tazón
    Guillermo Serrano
    Aintzane Diaz-Mazkiaran
    Mikel Hernaez
    Sofía Huerga
    Findlay Bewicke-Copley
    Ana Rio-Machin
    Matthew T. Maurano
    María Díez-Campelo
    David Valcarcel
    Kevin Rouault-Pierre
    David Lara-Astiaso
    Teresa Ezponda
    Felipe Prosper
    Nature Communications, 13
  • [33] Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)
    Valent, P
    Wimazal, F
    Schwarzinger, I
    Sperr, WR
    Geissler, K
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (13-14) : 515 - 536
  • [34] MOLECULAR PATHOGENESIS AND PROGNOSTIC STRATIFICATION OF MYELODYSPLASTIC SYNDROMES
    Cazzola, M.
    HAEMATOLOGICA, 2022, 107 : 1 - 2
  • [35] New clues to the molecular pathogenesis of myelodysplastic syndromes
    Jadersten, Martin
    Helistrom-Lindberg, Eva
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (08) : 1390 - 1396
  • [36] Myelodysplastic syndromes: molecular pathogenesis and genomic changes
    Nolte, Florian
    Hofmann, Wolf-K.
    ANNALS OF HEMATOLOGY, 2008, 87 (10) : 777 - 795
  • [37] Pathogenesis, biology, and management of myelodysplastic syndromes in children
    Haas, OA
    Gadner, H
    SEMINARS IN HEMATOLOGY, 1996, 33 (03) : 225 - 235
  • [38] Myelodysplastic syndromes: From pathogenesis and prognosis to treatment
    Fenaux, P
    SEMINARS IN HEMATOLOGY, 2004, 41 (02) : 6 - 12
  • [39] miRNAs, Immune Signaling, and Myelodysplastic Syndromes Pathogenesis
    Karsan, Aly
    BLOOD, 2014, 124 (21)
  • [40] Pathogenesis of immunological abnormalities in myelodysplastic syndromes.
    Okamoto, T
    Okada, M
    Takemoto, Y
    Kanamaru, A
    Kakishita, E
    BLOOD, 1997, 90 (10) : 2316 - 2316
12345